Skip to content

Efficacy of Adductor Canal Block for Anterior Cruciate Ligament Surgery

Efficacy of Adductor Canal Block for Anterior Cruciate Ligament Surgery: A Prospective Double Blinded Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05532618
Acronym
DUAL
Enrollment
34
Registered
2022-09-08
Start date
2022-08-01
Completion date
2023-08-01
Last updated
2023-09-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anterior Cruciate Ligament Injuries

Keywords

adductor canal block

Brief summary

The goal of this study is to objectify the postoperative pain level, the use of opiates and postoperative nausea and vomiting after adding the adductor canal block to the standard pain regiment after anterior cruciate ligament surgery

Detailed description

Patients scheduled for anterior cruciate ligament surgery will be randomized in an intervention and control group following informed consent. Before surgery, patients will receive an adductor canal bock with Levobupivacaine (intervention group) or 0.9% saline (control group). Following surgery, pain intensity, analgesic consumption and pain satisfaction will be recorded bij patients in a diary for 48 hours.

Interventions

PROCEDUREAdductor canal block

Before anterior cruciate ligament surgery an adductor canal block will be placed using ultrasound.

DRUGLevobupivacaine

Levobupivacaine

DRUGPlacebo

10 ml of sodium chloride 0.9%

Sponsors

St. Antonius Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Masking description

Medication is prepared by study personell not otherwise involved in the study according to a computer generated randomization plan. This plan will be available for analyses after the study. Primary investigator is able to retreive the allocation prematurely if indicated (emergency).

Intervention model description

Patients are randomized to receive an intervention (nerve block) with either an active drug or placebo.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Age 18 or older * Undergoing anterior cruciate ligament surgery under general anesthesia * ASA I-III

Exclusion criteria

* Contraindication for locoregional anesthesia; infection at the target puncture site, allergy to local anesthetics, * Neuromuscular disorders

Design outcomes

Primary

MeasureTime frameDescription
Postoperative pain levelWithin first 48 hours after surgeryUsing Numerical Rating Scales for pain from 1 to 10, 1 is no pain, 10 is the worst pain you can imagine

Secondary

MeasureTime frameDescription
Opiate useWithin first 48 hours after surgerypostoperative use of opiates (Morphine equivalent dose (mg))
NauseaWithin first 48 hours after surgeryPostoperative nausea (yes/no)
Block resultwithin first 24 hours after surgeryIf there's any loss of motor function (no quadriceps paresis, partial quadriceps paresis, complete quadriceps paresis.) using bromage score
Patient satisfaction48 hours after surgeryUsing Numerical Rating Scales from 1 to 10, 1 is not satisfied at all, 10 is completely satisfied

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026